An extensive catalogue of safe, effective, practical and technologically advanced products, packaged in sterile and non-sterile single-dose or multi-dose containers.


We offer comprehensive consultation covering all stages from planning to the finished packaged product, taking in the various development and control stages.


We work in partnership with top producers of primary containers, with a view to combining practicality and the safeguarding of product properties


Ours is a company made up of individuals. Our clients can count on each and every one of us, on our personal and professional abilities and on our loyalty.

We are a pharmaceutical company licensed to produce:

  • Medicinal products for human use
    Authorisation of the Italian Medicines Agency (AIFA) for the production (preparation, packaging, analyses and release) of low-volume liquids (including corticosteroids) produced by aseptic processing.
  • Medicinal products for veterinary use
    AuAuthorisation of the Italian Ministry of Health (Office V Manufacture of Veterinary Medicinal Products) for the production (preparation, packaging, analyses and release) of low-volume liquids produced by aseptic processing.

We specialise in contract manufacturing in compliance with EudraLex, volume 4, Good Manufacturing Practice (GMP) guidelines.

The management system of both our plants (Sant’Agata Bolognese and Rovereto sul Secchia) complies with ISO 13485:2016 (Medical devices – Quality management system – Requirements for regulatory purposes) which allows development, direct and contract production and sale of sterile and non-sterile medical devices in liquid, gel and cream form, in single-dose and multi-dose containers. Indeed, we are private label medical device manufacturers as well as producers of medical devices on behalf of other manufacturers.

Our Rovereto sul Secchia plant operates in compliance with ISO 22716:2007 (Cosmetics Good Manufacturing Practices (GMP) – Guidelines on Good Manufacturing Practices) which allows the contract manufacturing of cosmetics, also by aseptic processing.

“We monitor the quality of the products, services and information that we offer our clients because we know that the health and wellbeing of end consumers ultimately depends on this. That is why all our efforts are geared towards defining stable, safe processes and supplying controlled, compliant products, minimising risks and guaranteeing excellent, repeatable performance.”

Marco Albasini
Chief Operating Officer